Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Item
http://www.wikidata.org/entity/Q35051678
Avoiding hepatic metastasis naturally: Lessons from the cotton top tamarin (Saguinus oedipus)Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimensMolecular markers predictive of chemotherapy response in colorectal cancerIMAC capture of recombinant protein from unclarified mammalian cell feed streamsBaseline, Trend, and Normalization of Carcinoembryonic Antigen as Prognostic Factors in Epidermal Growth Factor Receptor-Mutant Nonsmall Cell Lung Cancer Patients Treated With First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia.Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed.Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis.Clinical significance of changes in systemic inflammatory markers and carcinoembryonic antigen levels in predicting metastatic colorectal cancer prognosis and chemotherapy response.The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study.A novel therapeutic strategy of personalized medicine based on anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer.
P2860

Baseline carcinoembryonic antigen (CEA) serum levels predict bevacizumab-based treatment response in metastatic colorectal cancer

Item
http://www.wikidata.org/entity/Q35051678
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@ast
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@en
type
label
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@ast
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@en
prefLabel
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@ast
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Baseline carcinoembryonic anti ...... n metastatic colorectal cancer
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932